West Virginia HB 4640: Relating to drugs and adding a provision relating to the scheduling of crystalline polymorph psilocybin approved by the Food and Drug Administration

Status: On 1st reading, House Calendar (as of 2026-02-02)

State: West Virginia · Session: 2026 · Bill: HB 4640

Subjects: Health

Sponsors: Worrell, Hite

View West Virginia HB 4640 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.